These two groups were sex- and age-matched and had similar demographic and clinical data, except for peak levels of creatine phosphokinase (CPK) and cardiac troponin T (cTnT) which, as expected, were higher in patients developing HF (Table 1). The gene discussed is TNNT2; the disease is hydrops fetalis.